Matches in SemOpenAlex for { <https://semopenalex.org/work/W1825277477> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W1825277477 endingPage "4" @default.
- W1825277477 startingPage "1511" @default.
- W1825277477 abstract "The effects of the diluent, the container, the i.v. set, and the drug concentration on the adsorption of urokinase to i.v. administration systems were studied, along with the compatibility of urokinase with plastic and glass syringes. Solutions of urokinase 1500 and 5000 IU/mL in 0.9% sodium chloride injection and 5% dextrose injection in glass and polyvinyl chloride (PVC) containers were sampled at 2 and 30 minutes. Administration sets were attached to PVC containers containing the urokinase-5% dextrose injection solutions, and samples were collected at 90 and 150 minutes. Glass and polypropylene syringes containing urokinase 5000 IU/mL in 0.9% sodium chloride injection or 5% dextrose injection were sampled at 0, 4, 8, and 24 hours. Urokinase activity was measured by an in vitro clot lysis assay. No urokinase diluted in 0.9% sodium chloride injection adsorbed to glass or PVC containers. For urokinase 1500 IU/mL in 5% dextrose injection, a loss of 15% to 20% occurred almost instantaneously in PVC containers; additional losses to the infusion sets were minimal. However, for urokinase 5000 IU/mL in 5% dextrose injection, no losses were observed in the PVC systems. No drug loss to glass bottles was seen for urokinase 1500 or 5000 IU/mL in 5% dextrose injection. Urokinase potency remained constant in polypropylene and glass syringes for 24 hours. To minimize urokinase sorption to PVC containers, higher concentrations of urokinase diluted in 5% dextrose injection should be used, provided that clinical safety and efficacy are not compromised. The use of 0.9% sodium chloride injection as a diluent also prevents sorption losses." @default.
- W1825277477 created "2016-06-24" @default.
- W1825277477 creator A5000164125 @default.
- W1825277477 creator A5024984557 @default.
- W1825277477 creator A5050232674 @default.
- W1825277477 creator A5073159318 @default.
- W1825277477 date "1991-07-01" @default.
- W1825277477 modified "2023-10-18" @default.
- W1825277477 title "Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes." @default.
- W1825277477 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1882883" @default.
- W1825277477 hasPublicationYear "1991" @default.
- W1825277477 type Work @default.
- W1825277477 sameAs 1825277477 @default.
- W1825277477 citedByCount "7" @default.
- W1825277477 countsByYear W18252774772014 @default.
- W1825277477 countsByYear W18252774772015 @default.
- W1825277477 crossrefType "journal-article" @default.
- W1825277477 hasAuthorship W1825277477A5000164125 @default.
- W1825277477 hasAuthorship W1825277477A5024984557 @default.
- W1825277477 hasAuthorship W1825277477A5050232674 @default.
- W1825277477 hasAuthorship W1825277477A5073159318 @default.
- W1825277477 hasConcept C13965031 @default.
- W1825277477 hasConcept C141071460 @default.
- W1825277477 hasConcept C175804951 @default.
- W1825277477 hasConcept C178790620 @default.
- W1825277477 hasConcept C185592680 @default.
- W1825277477 hasConcept C2776866176 @default.
- W1825277477 hasConcept C2776892390 @default.
- W1825277477 hasConcept C2778695967 @default.
- W1825277477 hasConcept C43617362 @default.
- W1825277477 hasConcept C537181965 @default.
- W1825277477 hasConcept C71924100 @default.
- W1825277477 hasConceptScore W1825277477C13965031 @default.
- W1825277477 hasConceptScore W1825277477C141071460 @default.
- W1825277477 hasConceptScore W1825277477C175804951 @default.
- W1825277477 hasConceptScore W1825277477C178790620 @default.
- W1825277477 hasConceptScore W1825277477C185592680 @default.
- W1825277477 hasConceptScore W1825277477C2776866176 @default.
- W1825277477 hasConceptScore W1825277477C2776892390 @default.
- W1825277477 hasConceptScore W1825277477C2778695967 @default.
- W1825277477 hasConceptScore W1825277477C43617362 @default.
- W1825277477 hasConceptScore W1825277477C537181965 @default.
- W1825277477 hasConceptScore W1825277477C71924100 @default.
- W1825277477 hasIssue "7" @default.
- W1825277477 hasLocation W18252774771 @default.
- W1825277477 hasOpenAccess W1825277477 @default.
- W1825277477 hasPrimaryLocation W18252774771 @default.
- W1825277477 hasRelatedWork W133908214 @default.
- W1825277477 hasRelatedWork W1806064976 @default.
- W1825277477 hasRelatedWork W1938163566 @default.
- W1825277477 hasRelatedWork W1938979647 @default.
- W1825277477 hasRelatedWork W2034895799 @default.
- W1825277477 hasRelatedWork W2065714609 @default.
- W1825277477 hasRelatedWork W2089181912 @default.
- W1825277477 hasRelatedWork W4285589489 @default.
- W1825277477 hasRelatedWork W2185652042 @default.
- W1825277477 hasRelatedWork W3139811806 @default.
- W1825277477 hasVolume "48" @default.
- W1825277477 isParatext "false" @default.
- W1825277477 isRetracted "false" @default.
- W1825277477 magId "1825277477" @default.
- W1825277477 workType "article" @default.